title: Pharmacology of the memory process.
abstract: Rather than reviewing once again the published literature on drugs which are capable of modifying the memory process, the authors stress the methodological difficulties which impede the development of such products. At the moment, substances which act on neurotransmission systems, and in particular cholinergic and gabaergic agents, seem to be good candidates. The choice of the molecule to be studied in man depends on the neurochemical physiopathology of the memory disorder which one seeks to correct. For this reason, one tries to select an animal model of memory which is closest to the clinical situation pertaining to man on which the tested molecule might act favorably.
authors.affiliation: Laboratoire de Pharmacologie Clinique, Faculté de Médecine, Rennes, France.
authors.forename: H
authors.initials: H
authors.lastname: Allain
authors.forename: P
authors.initials: P
authors.lastname: Moran
authors.forename: D
authors.initials: D
authors.lastname: Bentue-Ferrer
authors.forename: J P
authors.initials: JP
authors.lastname: Martinet
authors.forename: A
authors.initials: A
authors.lastname: Lieury
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D008568:Memory / Q000187:drug effects*; D008569:Memory Disorders / Q000503:physiopathology*; D018377:Neurotransmitter Agents / Q000494:pharmacology
chemical_list: D018377:Neurotransmitter Agents